News
A new study has found that an anti-obesity drug called tirzepatide, which is sold under the names Mounjaro for diabetes and ...
The Canadian Press on MSN3h
B.C. limits sales of two more diabetes drugs amid off-label use for weight lossBritish Columbia's Health Ministry is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...
3h
The Vancouver Sun on MSNB.C. restricts sales of two more diabetes drugs amid weight-loss demandThe B.C. government is restricting the sales of two more diabetes drugs to people outside Canada amid rising demand for the ...
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.
Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...
Presented by AstraZeneca{beacon} Health Care Health Care The Big Story CMS targets hospitals with site-neutral drug ruleThe ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
In this week’s edition of InnovationRx, we look at how Daniel Nadler became a billionaire building a ChatGPT for doctors, big news from two Chinese biotech companies, what doctors think about AI and ...
In postmenopausal women with overweight or obesity receiving tirzepatide, use of MHT is associated with superior weight loss outcomes.
Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results